Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30
Abstract
The origin of the polybasic furin cleavage site (FCS) of SARS-CoV-2 remains a central question in debates on the emergence of COVID-19. One hypothesis proposes a genetic relationship between the SARS-CoV-2 S1/S2 motif RRAR and the RRVR sequence found in the mouse-adapted MERS-CoV strain MERS-MA30. Here, we combined large-scale bioinformatic analysis with experimental virology to evaluate this scenario. Analysis of over 17 million SARS-CoV-2 genomes revealed that the S:684V substitution corresponding to RRVR occurred repeatedly but only sporadically, never became phylogenetically basal, and showed limited geographic and temporal spread. Using reverse genetics, we generated SARS-CoV-2 variants encoding RRVR and demonstrated that S:684V consistently reduced viral entry efficiency and competitive fitness in multiple cell systems, including human respiratory epithelial cultures. RRVR variants did not evolve toward RRAR but instead accumulated alternative substitutions. These findings do not support an evolutionary relationship between MERS-MA30 and the SARS-CoV-2 FCS.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (9)
Sarah M. Metzger
Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin
Terry C. Jones
Jenny I. J. Meier
Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin
Anja Richter
Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin
Mark-Christian Klassen
Leibniz Research Laboratories for Biotechnology and Artificial Organs and National Center for Lung Research, Hannover Medical School
Ruth Olmer
Leibniz Research Laboratories for Biotechnology and Artificial Organs and National Center for Lung Research, Hannover Medical School
Nicolai Diegmüller
Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin
Kim C. Heimsch
Institute of Virology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität Berlin
Christian Drosten